News
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback